Michael McConnell

Head of Cardiovascular Health Innovations, Verily Life Sciences

Dr. McConnell is an MIT-trained bioengineer who completed his MD at Stanford followed by cardiology fellowship and cardiovascular imaging training at Brigham & Women’s and Beth Israel Hospitals in Boston. He joined the Stanford faculty in 1998 and is currently on partial leave of absence working nearby at Verily Life Sciences. He continues part-time clinical activities at Stanford in imaging and Preventive Cardiology. He previously directed the Cardiovascular MRI Program and the Preventive Cardiology Clinic in the Stanford Division of Cardiovascular Medicine. His research expertise includes novel MRI and molecular imaging techniques, from mouse to man, to evaluate coronary artery and vascular diseases, including the characterization of atherosclerotic plaque and vascular inflammation. He directed the NIH-funded Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford (CVIS). He was also the Director of Cardiovascular Health Innovation and led efforts to integrate mobile health technologies to improve the care of patients with or at risk for cardiovascular disease, including PI of the MyHeart Counts mHealth research study.